Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

NCT03196661 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

588

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A

Interventions

BIOLOGICAL: Influenza A (H7N9) virus vaccine

Sponsor

Hualan Biological Bacterin Co. Ltd.